Factor VIII Activity, ReFacto
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
New Recombinant XYNTHA Now Available for Patients with Hemophilia A
...advised to consult
with their health care professional and to bring an adequate supply of
XYNTHA for anticipated treatment.
Indication for ReFacto
is indicated for the control and prevention of hemorrhagic
episodes and for surgical prophylaxis and for short-term routine
prophylaxis to reduce the ...
ReFacto® Antihemophilic Factor (recombinant)
Learn about the prescription medication Refacto
(Antihemophilic Factor), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
is a glycoprotein with an ... activity of ReFacto
is 11,200-15,500 IU per milligram of protein. ... ReFacto
is formulated as a sterile, nonpyrogenic, ...
Refacto (Antihemophilic Factor) - Drug Info, Side Effects, Research ...Refacto
(Antihemophilic Factor) - Drug Info, Side Effects, Research, Clinical Trials ... ReFacto
has in vitro functional characteristics comparable to those of ...
® Antihemophilic Factor (Recombinant) Indication. ReFacto
is indicated for the control and prevention of hemorrhagic episodes and ...
ReFacto - definition of ReFacto by the Free Online Dictionary ...
Information about ReFacto
in the free online English dictionary and encyclopedia. ... ReFacto
. Refactor. Refactor. Refactorable number. Refactored. Refactoring ...
WYE Biovitrum AB announces extension of ReFacto supply agreement with Wyeth
TradingMarkets News for WYE - Biovitrum AB announces extension of ReFacto
supply agreement with Wyeth ... ReFacto
, the agreement also includes Xyntha/ReFacto